24/05/2016 10:56:25 1-888-992-3836 (toll free) Free Membership Login
   

Alexza

Visual Financials
Company Name: Alexza Pharmaceuticals Inc
Ticker Symbol: ALXA
CIK Number: 0001344413
WWW Address: http://www.alexza.com
CEO: Thomas B. King
No. of Employees: 27
Common Issue Type: CS
Business Description:Alexza Pharmaceuticals, Inc. is a pharmaceutical company focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions.

 
Industry Information: DRUGS - Drug Manufacturers - Other [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 0.96 Unchanged 0.0 0.9111 1.44  0.96 0.92 -
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 20.9 21.8 0.00 -1.08 0.00 0.0 0.0 1.60 - 0.22
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close0.95$
PE Ratio - LTM0.0
Market Capitalisation20.9mil
Latest Shares Outstanding21.8mil
Earnings pS (EPS)-1.08$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee186,148$
Effective Tax Rate0.0%
Float19.1mil
Float as % of Shares Outstanding0.9%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue2.40%
Research & Devlopment (R&D) as % of Revenue2.30%
Gross Profit Margin-320.4%
EBITDA Margin-196.2%
Pre-Tax Profit Margin0.0%
Assets Turnover13.2%
Return on Assets (ROA)-55.9%
Return on Equity (ROE)0.0%
Return on Capital Invested (ROCI)0.0%
Current Ratio0.2
Leverage Ratio (Assets/Equity)
Interest Cover-1.5
Total Debt/Equity (Gearing Ratio)
LT Debt/Total Capital0.0%
Working Capital pS-2.17$
Cash pS0.00$
Book-Value pS-3.42$
Tangible Book-Value pS-3.29$
Cash Flow pS-1.17$
Free Cash Flow pS-1.17$
KEY FIGURES (LTM): Price info
Price/Book Ratio-0.27
Price/Tangible Book Ratio0.00
Price/Cash Flow-0.8
Price/Free Cash Flow-0.8
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---1.12465,198512,925
4 Weeks0.960.520.6053.355240,9815,060,616
13 Weeks0.960.270.30206.9202184,25111,976,342
26 Weeks1.230.221.00-8.1-6168,45521,056,994
52 Weeks1.600.221.15-20.0-17103,52726,192,348
YTD0.960.22-32.931164,21516,093,104
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
0.920.920.630.660.820.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue-0.350.00.07
Income0.0
Dividend0.0
Capital SpendingNA
R&D-16.28NA-16.16
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %-61.3-61.3-28.1
Earnings %0.00.00.0
EPS %0.00.00.0
EPS $-0.91-0.913.76
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio-320.45
Current Ratio0.2
Quick Ratio (Acid Test)0.1
Liquidity Ratio (Cash)0.27
Receivables Turnover0.0
Average Collection Period
Working Capital/Equity0.0
Working Capital pS-2.17
Cash-Flow pS-1.61
Free Cash-Flow pS-1.61
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio-8.31
Financial Leverage Ratio (Assets/Equity)0.0
Debt Ratio461.4
Total Debt/Equity (Gearing Ratio)0.00
LT Debt/Equity0.00
LT Debt/Capital Invested-39.3
LT Debt/Total Liabilities0.0
Interest Cover-1.5
Interest/Capital Invested-19.43
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio1.36
Current P/E Ratio - LTM0.00
Enterprise Value (EV)/EBITDA-9.22
Enterprise Value (EV)/Free Cash Flow-0.30
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM-0.27
Price/Cash Flow Ratio-0.8
Price/Free Cash Flow Ratio - LTM-0.8
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM0.0
P/E Ratio (26 weeks ago) - LTM0.0
P/E Ratio (52 weeks ago) - LTM0.0
5-Y High P/E Ratio-15.8
5-Y Low P/E Ratio-0.2
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM0.0
PER SHARE FIGURES
LT Debt pS0.00
Current Liabilities pS3.44
Tangible Book Value pS - LTM-3.29
Book Value pS - LTM-3.42
Capital Invested pS-3.29
Cash pS - LTM0.00
Cash Flow pS - LTM-1.17
Free Cash Flow pS - LTM-1.17
Earnings pS (EPS)-1.08
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin-635.52
Free Cash Flow Margin 5YEAR AVG-501.11
Net Profit Margin-4.2
Net Profit Margin - 5YEAR AVRG.-5.1
Equity Productivity-0.07
Return on Equity (ROE)0.0
Return on Equity (ROE) - 5YEAR AVRG.
Capital Invested Productivity-0.07
Return on Capital Invested (ROCI)0.0
Return on Capital Invested (ROCI) - 5YEAR AVRG.
Assets Productivity0.10
Return on Assets (ROA)-0.6
Return on Assets (ROA) - 5YEAR AVRG.-0.7
Gross Profit Margin-320.4
Gross Profit Margin - 5YEAR AVRG.-0.5
EBITDA Margin - LTM-196.2
EBIT Margin - LTM-255.9
Pre-Tax Profit Margin0.0
Pre-Tax Profit Margin - 5YEAR AVRG.
Effective Tax Rate0.0
Effective Tax Rate - 5YEAR AVRG.0.0
EFFICIENCY RATIOS
Cash Conversion Cycle
Revenue per Employee186,148
Net Income per Employee
Average Collection Period
Receivables Turnover0.0
Day's Inventory Turnover Ratio
Inventory Turnover0.0
Inventory/Sales0.0
Accounts Payble/Sales8.79
Assets/Revenue10.00
Net Working Capital Turnover-0.11
Fixed Assets Turnover1.34
Total Assets Turnover0.1
Revenue per $ Cash0.65
Revenue per $ Plant1.51
Revenue per $ Common Equity0.00
Revenue per $ Capital Invested0.00
Selling, General & Adm/tive (SG&A) as % of Revenue242.8
SG&A Expense as % of Revenue - 5YEAR AVRG.0.0
Research & Devlopment (R&D) as % of Revenue233.1
R&D Expense as % of Revenue - 5YEAR AVRG.233.1

  
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:32 V:us D:20160524 09:56:25